1887

Abstract

Daptomycin is a novel lipopeptide with activity against Gram-positive organisms including enterococci. It is licensed for the treatment of bacteraemia and right-sided endocarditis, but not endocarditis due to spp. We report a case of enterococcal prosthetic valve endocarditis with an aortic root abscess in an elderly patient who was not fit for surgery. The patient's endocarditis relapsed 9 weeks after a 6 week course of daptomycin.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.016253-0
2010-04-01
2019-11-23
Loading full text...

Full text loading...

/deliver/fulltext/jmm/59/4/482.html?itemId=/content/journal/jmm/10.1099/jmm.0.016253-0&mimeType=html&fmt=ahah

References

  1. Arias, C. A., Torres, H. A., Singh, K. V., Panesso, D., Moore,J., Wanger, A. & Murray, B. E. ( 2007; ). Failureof daptomycin monotherapy for endocarditis caused by an Enterococcus faecium strain with vancomycin-resistant and vancomycin-susceptible subpopulationsand evidence of in vivo loss of the vanA gene cluster. Clin Infect Dis 45, 1343–1346.[CrossRef]
    [Google Scholar]
  2. BNF ( 2008; ). British National Formulary, 55th edn. London: BMJ Publishing & RPS Publishing.
  3. Cunha, B. A., Mickail, N. & Eisenstein, L. ( 2007; ). E. faecalis vancomycin-sensitive enterococcal bacteremiaunresponsive to a vancomycin tolerant strain successfully treated with high-dosedaptomycin. Heart Lung 36, 456–461.[CrossRef]
    [Google Scholar]
  4. Durack, D. T., Lukes, A. S., Bright, D. K. & Duke EndocarditisService ( 1994; ). New criteria for diagnosis of infectiveendocarditis: utilization of specific echocardiographic findings. Am J Med 96, 200–209.[CrossRef]
    [Google Scholar]
  5. Elliott, T. S. J., Foweraker, J., Gould, F. K., Perry, J. D. &Sandoe, J. A. T. ( 2004; ). Guidelines for the antibiotictreatment of endocarditis in adults: report of the Working Party of the BritishSociety for Antimicrobial Chemotherapy. J Antimicrob Chemother 54, 971–981.[CrossRef]
    [Google Scholar]
  6. Enoch, D. A., Bygott, J. M., Daly, M. L. & Karas, J. A. ( 2007; ). Daptomycin. J Infect 55, 205–213.[CrossRef]
    [Google Scholar]
  7. Fraher, M. H., Corcoran, G. D., Creagh, S. & Feeney, E. ( 2007; ). Daptomycin-resistant Enteroccoccus faecium in a patient with no prior exposure to daptomycin. J HospInfect 65, 376–378.
    [Google Scholar]
  8. Kanafani, Z. A., Federspiel, J. J. & Fowler, V. G., Jr ( 2007; ). Infective endocarditis caused by daptomycin-resistantEnterococcus faecalis: a case report. Scand J Infect Dis 39, 75–77.[CrossRef]
    [Google Scholar]
  9. Lesho, E. P., Wortmann, G. W., Craft, D. & Moran, K. A. ( 2006; ). De novo daptomycin nonsusceptibility in aclinical isolate. J Clin Microbiol 44, 673 [CrossRef]
    [Google Scholar]
  10. Levine, D. P. & Lamp, K. C. ( 2007a; ). Daptomycin experience for enterococcal endocarditis from a registry.In Abstracts of the 9th International Symposium on Modern Concepts inEndocarditis and Cardiovascular Infections, p. 425. Heidelberg: InternationalSociety for Cardiovascular Infectious Diseases.
  11. Levine, D. P. & Lamp, K. C. ( 2007b; ). Daptomycin in the treatment of patients with infective endocarditis:experience from a registry. Am J Med 120, S28–S33.
    [Google Scholar]
  12. Lewis, J. S., II, Owens, A., Cadena, J., Sabol, K., Patterson,J. E. & Jorgensen, J. H. ( 2005; ). Emergence ofdaptomycin resistance in Enterococcus faecium during daptomycin therapy. Antimicrob Agents Chemother 49, 1664–1665.[CrossRef]
    [Google Scholar]
  13. Long, J. K., Choueiri, T. K., Hall, G. S., Avery, R. K. &Sekeres, M. A. ( 2005; ). Daptomycin-resistant Enterococcusfaecium in a patient with acute myeloid leukemia. Mayo ClinProc 80, 1215–1216.
    [Google Scholar]
  14. Mohan, S. S., McDermott, B. P. & Cunha, B. A. ( 2005; ). Methicillin-resistant Staphylococcus aureus prostheticaortic valve endocarditis with paravalvular abscess treated with daptomycin. Heart Lung 34, 69–71.[CrossRef]
    [Google Scholar]
  15. Mohr, J. F., Friedrich, L. V., Yankelev, S. & Lamp, K. C. ( 2009; ). Daptomycin for the treatment of enterococcalbacteraemia: results from the Cubicin Outcomes Registry and Experience (CORE). Int J Antimicrob Agents 33, 543–548.[CrossRef]
    [Google Scholar]
  16. Munoz-Price, L. S., Lolans, K. & Quinn, J. P. ( 2005; ). Emergence of resistance to daptomycin during treatment ofvancomycin-resistant Enterococcus faecalis infection. Clin Infect Dis 41, 565–566.[CrossRef]
    [Google Scholar]
  17. Schwartz, B. S., Ngo, P. D. & Guglielmo, B. J. ( 2008; ). Daptomycin treatment failure for vancomycin-resistant Enterococcus faecium infective endocarditis: impact of protein binding? Ann Pharmacother 42, 289–290.[CrossRef]
    [Google Scholar]
  18. Segreti, J. A., Crank, C. W. & Finney, M. S. ( 2006; ). Daptomycin for the treatment of gram-positive bacteremiaand infective endocarditis: a retrospective case series of 31 patients. Pharmacotherapy 26, 347–352.[CrossRef]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.016253-0
Loading
/content/journal/jmm/10.1099/jmm.0.016253-0
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error